Colossal Biosciences’ Ben Lamm and Andruil’s Palmer Luckey had an idea to genetically engineer war dogs for the U.S. military, law enforcement, and other emergency response teams. That idea, on Thursday, announced its emergence from stealth as Warhound, armed with $200 million in funding from investors including In-Q-Tel, Sequoia, and 8VC. The round values the company at $1.2 billion.

These are dogs that perform tasks that are dangerous for humans or difficult for machines, like bomb detection, searches, and other specialized operations. In its launch announcement, the company said that more than 80% of the working dogs used by the U.S. military come from Europe and less than half of them are fit for service.

So not only is there a dwindling supply of working dogs for these tasks, but the U.S. has also become increasingly reliant on foreign nations for dogs that play an important role in the U.S. military and in law enforcement. That is key for what Warhound is trying to do. The hope is that Colossal can use its technology to engineer dogs with “characteristics suited to demanding missions,” the company said in a press release.

S. military. The two kept in touch, and Lamm did more research, learning about the breeding issues. Many dogs do not make it through training because of genetic dispositions for issues like poor eyesight or the high possibilities of cancer, hip dysplasia, or muscle atrophy.

Source link